Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Cash & Equivalents (2020 - 2025)

Stemtech (STEK) has disclosed Cash & Equivalents for 6 consecutive years, with $255416.0 as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents fell 1.6% to $255416.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $255416.0 through Sep 2025, down 1.6% year-over-year, with the annual reading at $255298.0 for FY2024, 123.62% up from the prior year.
  • Cash & Equivalents hit $255416.0 in Q3 2025 for Stemtech, down from $272450.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.6 million in Q3 2021 to a low of $114166.0 in Q4 2023.
  • Historically, Cash & Equivalents has averaged $384703.2 across 5 years, with a median of $273999.0 in 2024.
  • Biggest five-year swings in Cash & Equivalents: surged 1372.4% in 2021 and later tumbled 92.3% in 2022.
  • Year by year, Cash & Equivalents stood at $828206.0 in 2021, then crashed by 84.0% to $132487.0 in 2022, then dropped by 13.83% to $114166.0 in 2023, then soared by 123.62% to $255298.0 in 2024, then increased by 0.05% to $255416.0 in 2025.
  • Business Quant data shows Cash & Equivalents for STEK at $255416.0 in Q3 2025, $272450.0 in Q2 2025, and $305836.0 in Q1 2025.